Identification of Circulating Endocan-1 and Ether Phospholipids as Biomarkers for Complications in Thalassemia Patients

Despite advances in our knowledge and attempts to improve therapies, β-thalassemia remains a prevalent disorder with increased risk for the development of cardiomyopathy. Using an untargeted discovery-based lipidomic workflow, we uncovered that transfusion-dependent thalassemia (TDT) patients had a...

Ausführliche Beschreibung

Bibliografische Detailangaben

Hauptverfasser:	Amy Botta, Anik Forest, Caroline Daneault, Kostas Pantopoulos, Adisak Tantiworawit, Arintaya Phrommintikul, Siriporn Chattipakorn, Nipon Chattipakorn, Christine Des Rosiers, Gary Sweeney
Format:	Artigo
Sprache:	Inglês
Veröffentlicht:	MDPI AG 2021-01-01
Schriftenreihe:	Metabolites
Schlagworte:	lipidomic biomarker diagnostic therapeutic thalassemia
Online-Zugang:	https://www.mdpi.com/2218-1989/11/2/70
Tags:	Tag hinzufügen Keine Tags, Fügen Sie das erste Tag hinzu!